Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: An animal model for sensorimotor gating deficits in schizophrenia

Psychopharmacology

Volumn 174, Issue 2, 2004, Pages 177-189

  Elmer, G I ^a   Sydnor, J ^a   Guard, H ^a   Hercher, E ^a   Vogel, M W ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Animal model; Cytosine arabinoside; Pre pulse inhibition; Schizophrenia; Sensorimotor gating

Indexed keywords

APOMORPHINE; CYTARABINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; MALE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRENATAL EXPOSURE; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX; STIMULUS RESPONSE;

EID: 3142693526     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1757-7     Document Type: Article

References (71)

1. Abdel-Aziz W, Jiang HY, Hickey RJ, Malkas LH (2000) Ara-C affects formation of cancer cell DNA synthesome replication intermediates. Cancer Chemother Pharmacol 45:312-319
2. Adlard BP, Dobbing J, Sands J (1975) A comparison of the effects of cytosine arabinoside and adenine arabinoside on some aspects of brain growth and development in the rat. Br J Pharmacol 54:33-39
3. Arnold SE, Franz BR, Gur RC, Gur RE, Shapiro RM, Moberg PJ, Trojanowski JQ (1995) Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 152:738-748
4. Bayer SA, Altman J, Russo RJ, Zhang X (1993) Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14:83-144
5. Benes FM, Sorensen I, Bird ED (1991) Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 17:597-608
6. Borrell J, Vela JM, Arevalo-Martin A, Molina-Holgado E, Guaza C (2002) Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26:204-215
7. Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia: human and animal model studies. Arch Gen Psychiatry 47:181-188
8. Braff DL, Swerdlow NR, Geyer MA (1999) Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry 156:596-602
9. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234-258
10. Cadenhead KS, Geyer MA, Butler RW, Perry W, Sprock J, Braff DL (1997) Information processing deficits of schizophrenia patients: relationship to clinical ratings, gender and medication status. Schizophr Res 28:51-62
11. Chen S, Hillman DE (1986) Selective ablation of neurons by methylazoymethanol during pre- and postnatal brain development. Exp Neurol 94:103-119
12. Christison GW, Casanova MF, Weinberger DR, Rawlings R, Kleinman JE (1989) A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. Arch Gen Psychiatry 46:1027-1032
13. Courtney MJ, Coffey ET (1999) The mechanism of Ara-C-induced apoptosis of differentiating cerebellar granule neurons. Eur J Neurosci 11:1073-1084
14. Dambska M, Haddad R, Kozlowski PB, Lee MH, Shek J (1982) Telencephalic cytoarchitectonics in the brains of rats with graded degrees of micrencephaly. Acta Neuropathol 58:203-209
15. Depatie L, Lal S (2001) Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma? J Psychiatr Neurosci 26:203-220
16. Duval F, Mokrani MC, Crocq MA, Bailey PE, Diep TS, Correa H, Macher JP (2000) Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry 24:207-225
17. Ellenbroek BA, Lubbers LJ, Cools AR (2002) The role of hippocampal dopamine receptors in prepulse inhibition. Eur J Neurosci 15:1237-1243
18. Feinberg A, Zedeck MS (1980) Production of a highly reactive alkylating agent from the organospecific carcinogen methylazoxymethanol by alcohol dehydrogenase. Cancer Res 40:4446-4450
19. Feldon J, Weiner I (1988) Long-term attentional deficit in nonhandled males: possible involvement of the dopaminergic system. Psychopharmacology 95:231-236
20. Ferguson SA, Holson RR, Paule MG (1994) Effects of methylazoxymethanol- induced micrencephaly on temporal response diffferentiation and progressive ration responding in rats. Behav Neural Biol 62:77-81
21. Ferguson SA, Paule MG, Holson RR (1996) Functional effects of methylazoxymethanol-induced cerebellar hypoplasia in rats. Neurotoxicol Teratol 18:529-537
22. Fiala E, Stathopoulos C (1984) Metabolism of methylazoxymethanol acetate in the F344 rat and strain-2 guinea pig and its inhibition by pyrazole and disulfiram. J Cancer Res Clin Oncol 108:129-134
23. Fiore M, Talamini L, Angelucci F, Koch T, Aloe L, Korf J (1999) Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: a possible correlation with the development of schizophrenia-like deficits. Neuropharmacology 38:857-869
24. Fiore M, Korf J, Angelucci F, Talamini L, Aloe L (2000) Prenatal exposure to methylazoxymethanol acetate in the rat alters neurotrophin levels and behavior: considerations for neurodevelopmental diseases [In Process Citation]. Physiol Behav 71:57-67
25. Fiore M, Aloe L, Westenbroek C, Amendola T, Antonelli A, Korf J (2001) Bromodeoxyuridine and methylazoxymethanol exposure during brain development affects behavior in rats: consideration for a role of nerve growth factor and brain derived neurotrophic factor. Neurosci Lett 309:113-116
26. Fiore M, Korf J, Antonelli A, Talamini L, Aloe L (2002) Long-lasting effects of prenatal MAM treatment on water maze performance in rats: associations with altered brain development and neurotrophin levels. Neurotoxicol Teratol 24:179-191
27. Freeman J, Barone S, Stanton M (1995) Disruption of cerebellar maturation by an antimitotic agent impairs the ontogeny of eyeblink conditioning in rats. J Neurosci 15:7301-7314
28. Geyer MA, Wilkinson LS, Humby T, Robbins TW (1993) Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psychiatry 34:361-372
29. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117-154
30. Ghaiarnia M, Moore H, Grace AA (1998) Enhanced behavioral effects of phencyclidine (PCP) in rats with developmental abnormalities of the temporal lobe. Soc Neurosci Abstr 24:2177
31. Gillies K, Price DJ (1993) The fates of cells in the developing cerebral cortex of normal and methylazoxymethanol acetate-lesioned mice. Eur J Neurosci 5:73-584
32. Gmeiner WH, Skradis A, Pon RT, Liu J (1998) Cytarabine-induced destabilization of a model Okazaki fragment. Nucleic Acids Res 26:2359-2365
33. Gray LE Jr, Kavlok RJ, Ostby J, Ferrell J, Rogers J, Gray K (1986) An evaluation of figure-eight maze activity and general behavioral development following prenatal exposure to forty chemicals: effects of cytosine arabinoside, dinocap, nitrofen, and vitamin A. Neurotoxicology 7:449-462
34. Groothuis DR, Benalcazar H, Allen CV, Wise RM, Dills C, Dobrescu C, Rothholtz V, Levy RM (2000) Comparison of cytosine arabinoside delivery to rat brain by intravenous, intrathecal, intraventricular and intraparenchymal routes of administration. Brain Res 856:281-290
35. Harrison PJ (1999a) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122:593-624
36. Harrison PJ (1999b) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122:593-624
37. Johnston MV, Coyle JT (1979) Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood. Brain Res 170:135-155
38. Jonsson SA, Luts A, Guldberg-Kjaer N, Brun A (1997) Hippocampal pyramidal cell disarray correlates negatively to cell number: implications for the pathogenesis of schizophrenia. Eur Arch Psychiatry Clin Neurosci 247:120-127
39. Jonsson SA, Luts A, Guldberg-Kjaer N, Ohman R (1999) Pyramidal neuron size in the hippocampus of schizophrenics correlates with total cell count and degree of cell disarray. Eur Arch Psychiatr Clin Neurosci 249:169-173
40. Koenig JI, Kirkpatrick B, Lee P (2002) Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27:309-318
41. Kovelman JA, Scheibel AB (1984) A neurohistological correlate of schizophrenia. Biol Psychiatry 19:1601-1621
42. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235-9240
43. Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R (1999) Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46:56-72
44. Matsutani T, Tamaru M, Hayakawa Y, Nagayoshi M, Nakahara T, Tsukada Y (1983) A neurochemical study of developmental impairment of the brain caused by the administration of cytosine arabinoside during the fetal or neonatal period of rats. Neurochem Res 8:1295-1306
45. Meltzer HY, Lee MA, Jayathilake K (2001) The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia. Neuropsychopharmacology 24:278-290
46. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436
47. Moore H, Grace AA (1997) Anatomical changes in limbic structures produced by MAM during brain development are associated with changes in physiological interactions among afferents to the nucleus accumbens. Soc Neurosci Abstr 23:2378
48. Moore H, Giracello D, Grace AA, Geyer MA (1999) Sensory gating deficits in rats with early disruption of limbic cortical development: relevance to schizophrenia. Soc Neurosci Abstr 25:1580
49. Ohno M (1984) Neuroanatomical study of somatomotor cortex in microcephalic mice induced by cytosine arabinoside. Brain Dev 6:528-538
50. Ono K, Tokunaga A, Mizukawa K, Kurose K, Tanaka H (1992) Abnormal expression of embryonic neural cell adhesion molecule (N-cam) in the developing mouse cerebellum after neonatal administration of cytosine arabinoside. Dev Brain Res 65:119-122
51. Percy DH (1975) Taratogenic effects of the pyrimidine analogues 5-iododeoxyuridine and cytosine arabinoside in late fetal mice and rats. Teratology 11:103-117
52. Perry W, Braff DL (1994) Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry 151:363-367
53. Perry W, Geyer MA, Braff DL (1999) Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Arch Gen Psychiatry 56:277-281
54. Sarraf CE, Ansari TW, Conway P, Notay M, Hill S, Alison MR (1993) Bromodeoxyuridine-labelled apoptosis after treatment with antimetabolites in two murine tumours and in small intestinal crypts. Br J Cancer 68:678-680
55. Scheibel AB, Kovelman JA (1981) Disorientation of the hippocampal pyramidal cell and its processes in the schizophrenia patients. Biol Psychiatry 16:101-102
56. Swerdlow NR, Geyer MA (1998) Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24:285-301
57. Swerdlow NR, Geyer MA (1999) Neurophysiology and neuropharmacology of short lead interval startle modification. In: Dawson ME, Schell AM, Bohmelt AH (eds) Startle modification: implications for neuroscience, cognitive science and clinical science. Cambridge University Press, Cambridge, pp 114-133
58. Swerdlow NR, Caine SB, Geyer MA (1991) Opiate-dopamine interactions in the neural substrates of acoustic startle gating in the rat. Prog Neuropsychopharmacol Biol Psychiatry 15:415-426
59. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 51:139-54
60. Swerdlow NR, Braff DL, Geyer MA (2000a) Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 11:185-204
61. Swerdlow NR, Taaid N, Halim N, Randolph E, Kim YK, Auerbach P (2000b) Hippocampal lesions enhance startle gating-disruptive effects of apomorphine in rats: a parametric assessment. Neuroscience 96:523-536
62. Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156:194-215
63. Talamini LM, Koch T, Ter Horst GJ, Korf J (1998) Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia. Brain Res 789:293-306
64. Talamini LM, Koch T, Luiten PG, Koolhaas JM, Korf J (1999) Interruptions of early cortical development affect limbic association areas and social behaviour in rats; possible relevance for neurodevelopmental disorders. Brain Res 847:105-120
65. Talamini LM, Ellenbroek B, Koch T, Korf J (2000) Impaired sensory gating and attention in rats with developmental abnormalities of the mesocortex. Implications for schizophrenia. Ann N Y Acad Sci 911:486-494
66. Tamminga CA, Schaffer MH, Smith RC, Davis JM (1978) Schizophrenic symptoms improve with apomorphine. Science 200:567-568
67. Tsuang MT, Stone WS, Faraone SV (2001) Genes, environment and schizophrenia. Br J Psychiatry 178: S18-24
68. Weinberger DR (1996) On the plausibility of "The neurodevelopmental hypothesis" of schizophrenia. Neuropsychopharmacology 14:1s-11s
69. Weiss IC, Feldon J (2001) Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology 156:305-326
70. Woodward DJ, Bickett D, Chanda R (1975) Purkinje cell dendritic alterations after transient developmental injury of the external granular layer. Brain Res 97:195-214
71. Zhang W-N, Bast T, Feldon J (2002) Effects of hippocampal N-methly-D-aspartate infusion on locomotor activity and prepulse inhibition: differences between the dorsal and ventral hippocampus. Behav Neurosci 116:72-84